GB1106728A - Diuretic and saliuretic sustained-release compositions - Google Patents

Diuretic and saliuretic sustained-release compositions

Info

Publication number
GB1106728A
GB1106728A GB2191566A GB2191566A GB1106728A GB 1106728 A GB1106728 A GB 1106728A GB 2191566 A GB2191566 A GB 2191566A GB 2191566 A GB2191566 A GB 2191566A GB 1106728 A GB1106728 A GB 1106728A
Authority
GB
United Kingdom
Prior art keywords
benzyl
ethyl
methyl
fatty
saliuretic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2191566A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba AG filed Critical Ciba AG
Publication of GB1106728A publication Critical patent/GB1106728A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB2191566A 1965-05-25 1966-05-17 Diuretic and saliuretic sustained-release compositions Expired GB1106728A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45876365A 1965-05-25 1965-05-25

Publications (1)

Publication Number Publication Date
GB1106728A true GB1106728A (en) 1968-03-20

Family

ID=23821997

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2191566A Expired GB1106728A (en) 1965-05-25 1966-05-17 Diuretic and saliuretic sustained-release compositions

Country Status (7)

Country Link
AT (1) AT266324B (fr)
BE (1) BE681486A (fr)
DE (1) DE1617372A1 (fr)
DK (1) DK113596B (fr)
FR (1) FR5501M (fr)
GB (1) GB1106728A (fr)
NL (1) NL6607151A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001051033A1 (fr) * 2000-01-14 2001-07-19 Ucb, S.A. Compositions pharmaceutiques solides pour la liberation controlee de substances actives
EA016634B1 (ru) * 2008-12-29 2012-06-29 Унилевер Н.В. Замороженные кондитерские изделия и напитки и их применение
US11806352B2 (en) 2010-05-19 2023-11-07 Upfield Europe B.V. Theobromine for increasing HDL-cholesterol

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001051033A1 (fr) * 2000-01-14 2001-07-19 Ucb, S.A. Compositions pharmaceutiques solides pour la liberation controlee de substances actives
EP1118321A1 (fr) * 2000-01-14 2001-07-25 Ucb, S.A. Compositions pharmaceutiques solides pour la libération contrôlée de substances actives
EA016634B1 (ru) * 2008-12-29 2012-06-29 Унилевер Н.В. Замороженные кондитерские изделия и напитки и их применение
US11806352B2 (en) 2010-05-19 2023-11-07 Upfield Europe B.V. Theobromine for increasing HDL-cholesterol

Also Published As

Publication number Publication date
NL6607151A (fr) 1966-11-28
DE1617372A1 (de) 1971-04-01
AT266324B (de) 1968-11-11
BE681486A (fr) 1966-11-24
FR5501M (fr) 1967-10-30
DK113596B (da) 1969-04-08

Similar Documents

Publication Publication Date Title
US3456049A (en) Gradual-release tablet
GB1002211A (en) Method of preparing sustained release pharmaceutical tablets
NL940014I1 (nl) Werkwijze voor de bereiding van een geneesmiddel met diuretische en anti-inflammatoire werking aldusverkrijgbaar therapeutisch voorwerp en werkwijze voor het bereiden van daarin te gebruiken 3-sulfamoylpyridine-derivaten
DK0461630T3 (da) Fremgangsmåde til fremstilling af mikrokugler
AR207004A1 (es) Procedimiento para producir derivados de fenil polienos de acidos carboxilicos farmaceuticamente activos
JPS6339566B2 (fr)
GB1106728A (en) Diuretic and saliuretic sustained-release compositions
GB1179938A (en) Medicinal Sustained-Release Tablets.
GB760403A (en) Improvements in or relating to enteric coatings
NL7807594A (nl) Werkwijze voor het bereiden van gedeeltelijk geneutra- liseerde gemengde esters van melkzuur, citroenzuur en partiele glycerolvetzuuresters.
GB742544A (en) Enteric products
NL166277C (nl) Werkwijze voor het bereiden van gemengde esters van hydroxycarbonzuren en partiele vetzuurglyceriden.
Segaloff et al. Hormonal therapy in cancer of the breast. XIII. The effect of 9 alpha-fluoro-17 alpha-methyl-delta 4-androsten3-one-11 beta-17 beta-diol (fluoxymetherone) therapy on clinical course and hormonal excretion
IE790098L (en) Solvent vehicle
JPS5616409A (en) Gamma-oryzanol pharmaceutical preparation
US3071511A (en) Prednisolone-21-oenanthate octyldodecanol eye lotion
ES369646A1 (es) Un procedimiento de preparacion de los derivados de acido 5-tiazol carboxilico.
NL7603461A (nl) D-homosteroiden en werkwijze voor de bereiding daarvan.
JPS5441321A (en) Remedy for skin diseases and its preparation
KR830001644B1 (ko) 서방출형 제제의 제조 방법
US4376119A (en) Benzothiazine derivative
NL7802596A (nl) Werkwijze voor het bereiden van etherderivaten van clavulanzuuresters.
GB843886A (en) Compositions for use in suppositories
US2898342A (en) 2(2'-propenylidene-amino)-1,3,4-thiadiazole-5-sulfonamide
IE37823B1 (en) Sulphamoyl-benzoic acids